SunMed to Acquire Avanos Medical’s Respiratory Health Business
Strengthens portfolio with market-defining BALLARD*, MICROCUFF* and endOclear® brands
Enhances position as premier, completely dedicated consumable breathing products company
Provides expanded North American manufacturing footprint and innovation expertise
Through the transaction, SunMed is adding market leading brands to its expansive and growing portfolio, providing healthcare providers and patients with even more options. The BALLARD*, MICROCUFF* and endOclear® brands include closed suction catheters, endotracheal tubes and oral care solutions, whose products have achieved strong trust, recognition and respect among healthcare providers around the world for their high quality and advanced technology. Included in the transaction, in addition to expanding its product lines with these respiratory consumables, SunMed is acquiring two Avanos manufacturing facilities in
“Adding these complementary brands into our growing portfolio solidifies SunMed’s leadership as the premier manufacturer of the anesthesia and respiratory consumables that define product excellence and serve patients across the continuum of care,” said Hank Struik, CEO of SunMed. “These products are the standard bearers of closed suction and endotracheal consumables and we deeply admire the clinical results that these exceptional products provide for patients in critical care and the trust they have built with practitioners. Leveraging the expertise behind these successful brands, this transaction also supports our ability to drive growth and innovation, not just for the respiratory brands we are acquiring, but for our comprehensive breathing care platform. Combined with our expansive anesthesia and respiratory consumables business, we are further strengthening SunMed’s ability to serve more clinicians around the world so they can provide the best patient outcomes.”
“Divesting our Respiratory Health business is a key element of Avanos’ ongoing three-year transformation process,” said Joe Woody, Avanos CEO. “We’re confident that SunMed is an excellent fit for our RH brands – including BALLARD*, MICROCUFF* and endOclear® – and that these products will be strong additions to the company’s robust portfolio.”
The proposed transaction, which is subject to customary closing conditions, is expected to be completed by late 2023.
About SunMed
SunMed, headquartered in
About Avanos Medical, Inc.
Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20230607005849/en/
SunMed
Media
FGS Global
sunmed@fgsglobal.com
Source: SunMed